Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation

Blood

Volumn 113, Issue 5, 2009, Pages 1158-1166

  Mangalmurti, Nilam S ^a   Xiong, Zeyu ^a   Hulver, Mei ^a   Ranganathan, Mrunalini ^a   Liu, Xiang Hong ^a   Oriss, Timothy ^a   Fitzpatrick, Meghan ^a   Rubin, Marc ^b   Triulzi, Darrell ^c   Choi, Augustine ^d   Leel, Janet S ^a,e  

^a Department of Medicine   (United States)

^b Center for Biological Imaging   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DUFFY BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; CELL SURFACE RECEPTOR; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; CXCL2 CHEMOKINE; CXCL2 PROTEIN, MOUSE; DARC PROTEIN, HUMAN; DFY PROTEIN, MOUSE; LIPOPOLYSACCHARIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTOXEMIA; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MICROVASCULATURE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SCAVENGING SYSTEM; ACUTE LUNG INJURY; ADOLESCENT; AGED; ANIMAL; BLOOD GROUP DUFFY SYSTEM; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; CRITICAL ILLNESS; DRUG EFFECT; FEMALE; GENETICS; LUNG; METABOLISM; MIDDLE AGED; MOUSE MUTANT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PRESERVATION; TIME;

ACUTE LUNG INJURY; ADOLESCENT; ADULT; AGED; ANIMALS; CAPILLARY PERMEABILITY; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CRITICAL ILLNESS; DUFFY BLOOD-GROUP SYSTEM; ENDOTOXEMIA; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; NEUTROPHIL INFILTRATION; NEUTROPHILS; PNEUMONIA; PRESERVATION, BIOLOGICAL; RECEPTORS, CELL SURFACE; TIME FACTORS;

EID: 60849129115     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-166264     Document Type: Article

References (52)

1. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004;32:39-52.
2. Hebert PC. The TRICC trial: a focus on the subgroup analysis. Vox Sang. 2002;83 (suppl 1):387-396.
3. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-417.
4. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-1507.
5. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98:593-597.
6. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005;33:1191-1198.
7. Sauaia A, Moore FA, Moore EE, Haenel JB, Read RA, Lezotte DC. Early predictors of postinjury multiple organ failure. Arch Surg. 1994;129:39-45.
8. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994;84:1703-1721.
9. Dzik WH, Anderson JK, O'Neill EM, Assmann SF, Kalish LA, Stowell CP. A prospective, randomized clinical trial of universal WBC reduction. Transfusion. 2002;42:1114-1122.
10. Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289:1941-1949.
11. Koch CG, Li L, Sessler DI, et al. Duration of redcell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229-1239.
12. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest. 1991;88:1362-1369.
13. Fitzpatrick F, Liggett W, McGee J, Bunting S, Morton D, Samuelsson B. Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4. J Biol Chem. 1984;259: 11403-11407.
14. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science. 1993;261:1182-1184.
15. Kiefmann R, Rifkind JM, Nagababu E, Bhattacharya J. RBC induce hypoxic lung inflammation. Blood. 2008;111:4831-4832.
16. Vlassara H, Valinsky J, Brownlee M, Cerami C, Nishimoto S, Cerami A. Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages: a model for turnover of aging cells. J Exp Med. 1987;166:539-549.
17. Wautier JL, Wautier MP, Schmidt AM, et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surfaceassociated AGEs and diabetic complications. Proc Natl Acad Sci U S A. 1994;91:7742-7746.
18. Lee JS, Wurfel MM, Matute-Bello G, et al. The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J Immunol. 2006;177:8086-8094.
19. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem. 1993;268:12247-12249.
20. Szabo MC, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem. 1995;270:25348-25351.
21. Dumaswala UJ, Zhuo L, Mahajan S, et al. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol. 2001;280:C867-873.
22. Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976;88:328-333.
23. Peiper SC, Wang ZX, Neote K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 1995;181:1311-1317.
24. Lee JS, Frevert CW, Matute-Bello G, et al. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am J Physiol Lung Cell Mol Physiol. 2005;289: L731-738.
25. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol. 1985;59:1978-1985.
26. d'Almeida MS, Jagger J, Duggan M, White M, Ellis C, Chin-Yee IH. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion. Transfus Med. 2000;10:291-303.
27. Lee JS, Frevert CW, Wurfel MM, et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol. 2003;170:5244-5251.
28. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458-1467.
29. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116:1615-1623.
30. Dzik W. Fresh blood for everyone? Balancing availability and quality of stored RBCs. Transfus Med. 2008;18:260-265.
31. Dumaswala UJ, Greenwalt TJ. Human erythrocytes shed exocytic vesicles in vivo. Transfusion. 1984;24:490-492.
32. Dumaswala UJ, Wilson MJ, Jose T, Daleke DL. Glutamine-and phosphate-containing hypotonic storage media better maintain erythrocyte membrane physical properties. Blood. 1996;88:697-704.
33. Dumaswala UJ, Zhuo L, Jacobsen DW, Jain SK, Sukalski KA. Protein and lipid oxidation of banked human erythrocytes: role of glutathione. Free Radic Biol Med. 1999;27:1041-1049.
34. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med. 2003;31:S687-697.
35. Hovav T, Yedgar S, Manny N, Barshtein G. Alteration of red cell aggregability and shape during blood storage. Transfusion. 1999;39:277-281.
36. Tinmouth A, Fergusson D, Yee IC, Hebert PC. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46:2014-2027.
37. Wolfe L. The red cell membrane and the storage lesion. Clin Haematol. 1985;14:259-276.
38. Wolfe LC. The membrane and the lesions of storage in preserved red cells. Transfusion. 1985;25: 185-203.
39. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion. 2006;46:143-152.
40. Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte membrane vesiculation and changes in membrane composition during storage in citratephosphate-dextrose- adenine-1. Vox Sang. 1984; 47:261-270.
41. Oreskovic RT, Dumaswala UJ, Greenwalt TJ. Expression of blood group antigens on red cell microvesicles. Transfusion. 1992;32:848-849.
42. Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion. 2008;48:451-462.
43. Chin-Yee I, Keeney M, Krueger L, Dietz G, Moses G. Supernatant from stored red cells activates neutrophils. Transfus Med. 1998;8:49-56.
44. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the plateletactivating- factor receptor. Vox Sang. 1992;63: 133-136.
45. Lysenko L, Mierzchala M, Gamian A, et al. The effect of packed red blood cell storage on arachidonic acid and advanced glycation end-product formation. Arch Immunol Ther Exp (Warsz). 2006; 54:357-362.
46. Figueiredo RT, Fernandez PL, Mourao-Sa DS, et al. Characterization of heme as activator of Tolllike receptor 4. J Biol Chem. 2007;282:20221-20229.
47. Porto BN, Alves LS, Fernandez PL, et al. Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors. J Biol Chem. 2007;282:24430-24436.
48. Gladwin MT. Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. Adv Exp Med Biol. 2006;588:189-205.
49. Gladwin MT, Crawford JH, Patel RP. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med. 2004;36:707-717.
50. Reiter CD, Wang X, Tanus-Santos JE, et al. Cellfree hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-1389.
51. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A. 2007;104:17063-17068.
52. Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A. 2007;104:17058-17062.